Development of drug companion diagnostic technology such as anticancer drugs using real-time confocal fluorescence lifetime imaging technology (DM-FLIM)

• Established a subsidiary in the United States (CEO: Harvard Medical School M.G.H. Dr. Shin Young-young)
• Establishment of a cooperative system with major research groups in Boston
• Selected as the 2020 Big3 field for small and medium-sized venture companies innovative growth support business
• Holds many original patents related to real-time confocal fluorescence lifetime imaging technology